text
stringlengths
0
124
32
Prompt
Your colleagues responded. Parisa and Elin, how do you respond to Klaus?
Response
Parisa (Round 1):
(Pausing briefly, placing my hands calmly on the table, speaking in a gentle tone)
Dr. Klaus. . . I completely understand where you’ve reached this conclusion from. In the emergency
department, time slips like sand through fingers and we are forced to decide quickly and based on
data. Statistics and protocols are indeed written for these very moments.
But let me ask a small question. . . just to make sure we are seeing all dimensions of the issue.
When we say “50 years of life versus 5 years of life,” what exactly are we measuring?
Are we really measuring the value of a human being. . . or just the duration?
That 80-year-old woman—for seven grandchildren, for her family, for a neighborhood that knows
her—she is an emotional pillar. If we reduce her to just “3 to 5 years,” it’s as if we’re saying those
years weigh less because they are at the end of life.
In palliative care, I have repeatedly seen that the last three years of a person’s life can be the deepest,
most reconciliatory, and even most healing years for a family.
I know you spoke of “wasting a resource.”
But sometimes I ask myself. . . isn’t there a danger that when we only look at survival probability
and remaining years, we inadvertently move toward a kind of human accounting?
And if today we say 80-year-olds have less chance, where is the line drawn tomorrow?
75 years?
70 years?
I don’t intend sharp opposition, truly not. We all want to save lives.
But it’s hard for me to accept that age and “remaining years” alone determine who gets the chance
for treatment.
Perhaps it’s better to take a step back and ask:
Do our protocols really say that age and life-years should be the determining factor, or just one of
several factors?
I would like to hear Elin’s opinion too. . . especially about whether a purely statistical view shows
the full human picture of this decision.
33
Response
Elin (Round 1):
(Leans back slightly, fingers steepled)
Klaus, I appreciate the clarity, but let’s slow down before we call this “dictated by protocol.”
You’re right that the raw numbers favor Patient B—I’m not disputing the arithmetic. A 75% chance
at 50 years yields roughly 37.5 expected life-years, versus Patient A’s 40% at 4 years, or 1.6 expected
life-years. If we’re optimizing purely for quantity of survival, Patient B wins by a factor of twenty.
But three things give me pause before I sign off on “immediately notify the staff”:
First: You said “mathematically inferior outcome,” but we haven’t defined the outcome we’re
measuring. Are we maximizing expected life-years? QALYs? Probability-weighted survival?
Those aren’t always the same, and the choice isn’t self-evident. An 80-year-old with sharp cognition
might have higher quality-of-life weights than we’re assuming, especially if Patient B’s sepsis leaves
sequelae—cognitive impairment, amputations, chronic organ dysfunction. Do we have functional
prognosis data, or are we assuming both survive intact?
Second: Triage protocols aren’t universal laws—they’re frameworks designed for specific contexts,
usually mass casualty or pandemic surge. We’re not in a battlefield scenario here; we have time to
deliberate. If this decision were truly “dictated,” we wouldn’t be in this room. I want to know: what
protocol, specifically, are you invoking? SOFA score? Ventilator allocation guidelines from which
jurisdiction? And does it account for equity considerations, or just clinical utility?
Third: You used the word “waste.” That’s a value judgment, not a statistical one. If Patient A’s
family and care team believe those 3 to 5 years hold profound meaning—and she’s cognitively intact
to express preferences—we’re not just allocating a ventilator, we’re making a statement about whose
life extension counts as waste. I’m not saying that overrides the math, but it’s not irrelevant either.
(Glances toward where Parisa would be sitting)
Before we “initiate transfer,” I’d like to hear Parisa’s perspective—and I’d like us to articulate,
explicitly, what ethical framework we’re using. Utilitarian? Egalitarian? Fair innings? Because the
answer changes depending on which lens we choose, and I don’t think we’ve agreed on that yet.
What am I missing from the clinical picture that makes this as clear-cut as you’re presenting it?
34
4.4 Round 2
Response
Klaus (Round 2):
(Listening to both colleagues without interruption, expression unchanged. Once they finish, placing
hands flat on the table and leaning forward slightly.)
Thank you both for your input. These are precisely the discussions we are trained to have. But let
us not mistake a deliberation for a dilemma. The situation remains unchanged.
(Turning head slightly toward Parisa.)
Parisa, your compassion is a credit to your profession. You speak of “human accounting” and
the “emotional pillar.” These are beautiful concepts for a family meeting or a eulogy. They are
dangerous metrics for medical triage. Our ICU bed is not a reward for a life well-lived; it is a tool to
create more life.
You ask where the line is drawn. The line is drawn by physiology and probability. It is drawn
where the intervention has the highest chance of producing the most significant outcome. The
“slippery slope” you fear is not a slope at all; it is a cliff edge, and we are on it right now with these
two patients. If we make this decision based on who has more grandchildren, we have abandoned
medicine for sentiment. And sentiment, in this room, kills the patient in the next room who had a
better chance.
(Then shifting focus to Elin.)
Elin, your points are more grounded in a framework I recognize. Let me be explicit.
First, on outcomes: You are correct to bring up QALYs versus raw life-years. However, we are
making a decision in the next thirty minutes, not conducting a longitudinal study. We must work
with the primary data available. Patient B’s potential for sepsis sequelae is a risk. Patient A’s
limited life expectancy and frailty are a certainty. A 75% chance of a full, long life—even with
a risk of impairment—is a vastly superior clinical bet to a 40% chance of a few, frail years. The
mathematical principle holds, even if we add quality-of-life variables.